Nancy Vitale's most recent trade in Voyager Therapeutics Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Voyager Therapeutics Inc | Nancy Vitale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Voyager Therapeutics Inc | Nancy Vitale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Voyager Therapeutics Inc | Nancy Vitale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Voyager Therapeutics Inc | Nancy Vitale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Voyager Therapeutics Inc | Nancy Vitale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Voyager Therapeutics Inc | Nancy Vitale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |